We are live on !
Find out more
Marshall Wace Portfolio holdings
AUM
$127B
Turnover
40.17%
1-Year Est. Return
46.06%
This Fund
S&P 500
This Quarter Est. Return
+26.15%
1 Year Est. Return
+46.06%
3 Year Est. Return
+142.12%
5 Year Est. Return
+190.33%
10 Year Est. Return
+787.47%
AUM
$127B
AUM Growth
+$26.3B
(+26%)
Cap. Flow
+$9.28B
Cap. Flow % of AUM
Cap. Flow %
7.32%
Top 10 Holdings %
Top 10 Hldgs %
37.66%
Holding
3,898
New
771
Increased
1,083
Reduced
1,182
Closed
795
Avg Time Held
Equity + Options
1
year
Top 10 Avg Time Held
Equity + Options
2.3
years
Top 20 Avg Time Held
Equity + Options
1.6
years
Avg Time Held Equity only
1
year
Top 10 Avg Time Held Equity only
2.4
years
Top 20 Avg Time Held Equity only
1.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$9.9B |
| 2 |
Costco
COST
|
+$907M |
| 3 |
AbbVie
ABBV
|
+$643M |
| 4 |
JPMorgan Chase
JPM
|
+$609M |
| 5 |
Bank of America
BAC
|
+$567M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.03B |
| 2 |
Mercado Libre
MELI
|
+$528M |
| 3 |
Broadcom
AVGO
|
+$514M |
| 4 |
Sandisk
SNDK
|
+$507M |
| 5 |
Marvell Technology
MRVL
|
+$499M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 34.91% |
| 2 | Technology | 20.64% |
| 3 | Consumer Discretionary | 9.1% |
| 4 | Healthcare | 8.21% |
| 5 | Financials | 7.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3151
PUT
KE Holdings
BEKE
$19B
| – | – |
-2,200
| Closed | -$32.9K | – |
|
3152
Franklin Templeton
BEN
$16B
| – | – |
-757,036
| Closed | -$17.9M | – |
|
3153
Bar Harbor Bankshares
BHB
$674M
| – | – |
-48,619
| Closed | -$1.58M | – |
|
3154
CALL
Baidu
BIDU
$26.8B
| – | – |
-200
| Closed | -$22.3K | – |
|
3155
CALL
Bilibili
BILI
$5.29B
| – | – |
-2,800
| Closed | -$63.2K | – |
|
|
3156
Bilibili
BILI
$5.29B
| – | – |
-13,998
| Closed | -$316K | – |
|
|
3157
PUT
Bilibili
BILI
$5.29B
| – | – |
-1,900
| Closed | -$42.9K | – |
|
3158
Bioceres Crop Solutions
BIOX
$13.8M
| – | – |
-702,478
| Closed | -$309K | – |
|
3159
PUT
Bank of New York Mellon
BNY
$100B
| – | – |
-100
| Closed | -$11.9K | – |
|
3160
BK Technologies
BKTI
$265M
| – | – |
-15,964
| Closed | -$1.19M | – |
|
3161
REalloys Inc
ALOY
$488M
| – | – |
-447,464
| Closed | -$4.37M | – |
|
3162
Blackbaud
BLKB
$2.31B
| – | – |
-19,577
| Closed | -$756K | – |
|
3163
Broadstone Net Lease
BNL
$3.25B
| – | – |
-194,855
| Closed | -$3.56M | – |
|
3164
Benitec Biopharma
BNTC
$306M
| – | – |
-71,832
| Closed | -$765K | – |
|
3165
CALL
BioNTech
BNTX
$22B
| – | – |
-2,900
| Closed | -$258K | – |
|
|
3166
PUT
BioNTech
BNTX
$22B
| – | – |
-2,500
| Closed | -$222K | – |
|
3167
PUT
Berkshire Hathaway Class B
BRK.B
$1.16T
| – | – |
-300
| Closed | -$144K | – |
|
3168
Streamex Corp
STEX
$47.8M
| – | – |
-536,920
| Closed | -$607K | – |
|
3169
CALL
Boston Scientific
BSX
$62.4B
| – | – |
-100
| Closed | -$6.28K | – |
|
3170
B2Gold
BTG
$6.61B
| – | – |
-87,800
| Closed | -$398K | – |
|
3171
Bioventus
BVS
$992M
| – | – |
-103,528
| Closed | -$945K | – |
|
3172
Broadwind
BWEN
$75M
| – | – |
-297,451
| Closed | -$619K | – |
|
3173
Byrna Technologies
BYRN
$108M
| – | – |
-141,591
| Closed | -$1.3M | – |
|
3174
Credit Acceptance
CACC
$5.63B
| – | – |
-6,183
| Closed | -$2.62M | – |
|
3175
CACI
CACI
$14.5B
| – | – |
-14,977
| Closed | -$8.15M | – |
|
Similar funds
Marshall Wace's Q2 2026 Portfolio in Review
As of Q2 2026, Marshall Wace held 3,898 positions worth $127B, up 26% from $100B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Marshall Wace deployed $9.28B of net new capital in Q2 2026, opening 771 new positions and adding to 1,083 existing holdings. Its largest new stake was LPL Financial: 975,627 shares worth $275M.
By sector, the portfolio is most concentrated in Miscellaneous at 35% of assets, up from 30% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was NVIDIA, an estimated $1.03B trimmed.
- Marshall Wace's largest Q2 2026 buy was LPL Financial: 975,627 shares worth $275M.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $9.9B increase.
- Marshall Wace's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $1.03B.
- Marshall Wace fully exited Merck in Q2 2026, selling an estimated $325M.
- Marshall Wace's ten largest holdings make up 38% of its $127B portfolio in Q2 2026.
- Marshall Wace opened 771 new positions and closed 795 in Q2 2026.
- Marshall Wace's portfolio value rose 26% quarter-over-quarter to $127B.
Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.